Clinical Trial Update: Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities [Phase 3]

View source ↗

Summary

Phase 3 trial update for endovenous ablation with and without polidocanol endovenous microfoam in patients with great saphenous vein incompetence and visible va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Great Saphenous Vein Incompetence
• Visible Varicosities

Drugs mentioned

• Endovenous ablation therapy
• Polidocanol Endovenous Microfoam (polidocanol endovenous microfoam)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Great Saphenous Vein Incompetence, Visible Varicosities | Phase 3 | Status: COMPLETED | Results posted: 2014-09-15